DALLAS, Nov. 30, 2009 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring Power3 Medical Products Inc. (OTCBB:PWRM). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
The investment report on Power3 Medical Products Inc. should be of particular interest to other healthcare technology companies: Vermillion Inc., Celera Corp. and Myriad Genetics.
It is available at: http://www.beaconequity.com/i/PWRM
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity
Power3 Medical Products Inc. (PWRM) is primarily engaged in commercializing its intellectual properties in the area of diagnosis and treatment of breast cancer, Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease and Parkinson's disease. The Company's products also comprise NuroPro, a blood serum protein neurodegenerative disease diagnostic screening test for disease diagnostics, such as neurological diseases of motor control, such as Parkinson's disease, ALS, and similarly disorders; ALS specific tests for ALS vs. ALS-like disorders; Alzheimer's disease specific tests; and a Parkinson's disease specific test.
Message Board Search for PWRM: http://www.boardcentral.com/boards/PWRM
In the report, the analyst notes:
"In early September PWRM announced the advance on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease" in the scientific journal Biochemical and Biophysical Research Communications.
"PWRM announced in late August that it has made significant advances in the technology for its BC-SeraPro serum protein-based blood test for diagnosis of early stage breast cancer, as disclosed in recent filings of three pending U.S. utility patent applications. As disclosed in the patent applications, PWRM has identified a group of 22 blood serum proteins with abnormal concentrations in women with breast cancer."
To read the entire report visit: http://www.beaconequity.com/i/PWRM
See what investors are saying about these stocks at: http://www.stockhideout.com/
BeaconEquity.com is one of the industry's largest small-cap report providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com
Beacon Equity Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Beacon Equity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.